What is the next step in managing a 6-year-old male with erratic behavior, full body aches, and thick green nasal discharge, who recently completed a course of treatment for strep throat (streptococcal pharyngitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)

This 6-year-old requires immediate evaluation for PANDAS, a post-streptococcal autoimmune neuropsychiatric syndrome, with urgent neuropsychiatric assessment, anti-streptococcal antibody titers (ASO, anti-DNase B), and consideration of immunomodulatory therapy if diagnosis is confirmed.

Clinical Recognition

This presentation is highly concerning for PANDAS rather than simple streptococcal pharyngitis complications:

  • Acute-onset neuropsychiatric symptoms following documented streptococcal infection (completed treatment course) including erratic behavior, aggression, screaming episodes, and anterograde amnesia are hallmark features of PANDAS 1, 2

  • Timeline correlation of 7-10 days post-streptococcal infection with behavioral deterioration fits the typical PANDAS presentation pattern 1

  • Age appropriateness: 6-year-old falls within the peak PANDAS age range (prepubertal children, typically 5-15 years) 3

  • The thick green nasal discharge and body aches suggest possible concurrent acute bacterial sinusitis, which requires separate evaluation 3

Immediate Diagnostic Workup

Confirm recent streptococcal exposure:

  • Obtain anti-streptolysin O (ASO) and anti-DNase B titers to document recent Group A Streptococcal infection, even though throat culture may now be negative 1, 2
  • These antibody titers rise 3-6 weeks after acute infection and provide retrospective confirmation 1

Rule out alternative diagnoses:

  • Brain MRI to exclude structural lesions, encephalitis, or other CNS pathology 1
  • Lumbar puncture if encephalitis is suspected based on fever, altered consciousness, or focal neurological findings 1
  • Complete blood count, comprehensive metabolic panel, and inflammatory markers (ESR, CRP) 1

Evaluate concurrent sinusitis:

  • The thick green nasal discharge persisting 7-10 days meets criteria for acute bacterial sinusitis (persistent symptoms >10 days without improvement) 3
  • Consider CT sinuses if severe symptoms or complications suspected 3

Treatment Algorithm

For Confirmed/Suspected PANDAS:

Antibiotic therapy:

  • Re-treat with different antibiotic class since azithromycin was already used and macrolide resistance is significant 4, 5
  • Prescribe amoxicillin 50 mg/kg/day divided twice daily for 10 days (maximum 1000 mg/day) as first-line alternative 1, 2
  • Alternative: amoxicillin-clavulanate if concurrent sinusitis confirmed (addresses both conditions) 3, 4

Immunomodulatory therapy (specialist consultation required):

  • Consider IVIG or plasmapheresis for severe, acute-onset PANDAS cases with significant functional impairment 1
  • Corticosteroids may provide benefit in acute severe presentations 1
  • These interventions require pediatric neuropsychiatry or immunology consultation 1

For Concurrent Acute Bacterial Sinusitis:

  • Amoxicillin with or without clavulanate 45-90 mg/kg/day divided twice daily for 10 days addresses both potential PANDAS and confirmed sinusitis 3
  • This dual approach is appropriate given the clinical presentation 3, 4

Critical Pitfalls to Avoid

Do not dismiss as behavioral problem:

  • Acute-onset neuropsychiatric symptoms with memory impairment in a previously normal child following streptococcal infection is PANDAS until proven otherwise 1, 2
  • Delayed recognition and treatment may worsen long-term neuropsychiatric outcomes 1

Do not assume streptococcal treatment was adequate:

  • The child may be a streptococcal carrier with inadequate eradication, requiring alternative antibiotic 3, 4
  • Macrolide resistance rates are significant in some U.S. regions (up to 20% resistance to azithromycin) 4, 5

Do not perform routine post-treatment throat culture:

  • Throat culture is not indicated unless symptoms persist or recur, as carriers may test positive without active infection 3, 4
  • Focus instead on anti-streptococcal antibody titers for PANDAS diagnosis 1, 2

Do not use azithromycin again:

  • Treatment failure with macrolides suggests either resistance or carrier state 4, 5
  • Switch to beta-lactam antibiotic (amoxicillin or amoxicillin-clavulanate) 2, 4

Specialist Referral

Urgent pediatric neuropsychiatry or neurology consultation is mandatory for:

  • Confirmation of PANDAS diagnosis 1
  • Consideration of immunomodulatory therapy 1
  • Long-term management planning including possible prophylactic antibiotics 1, 2

Pediatric infectious disease consultation if:

  • Multiple treatment failures occur 4
  • Family members have recurrent streptococcal infections suggesting household transmission 3

Follow-Up Strategy

  • Reassess within 48-72 hours after antibiotic initiation to evaluate neuropsychiatric symptom trajectory 1, 5
  • Patients with worsening symptoms after appropriate antibiotic initiation require immediate re-evaluation 5
  • Document baseline neuropsychiatric symptoms using standardized scales for monitoring treatment response 1
  • Consider testing household contacts if recurrent infections occur, treating those with positive cultures 3

References

Guideline

Treatment of Pharyngitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Persistent Sore Throat After Completed Azithromycin Course for Strep Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Streptococcal Pharyngitis: Rapid Evidence Review.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.